APA (7th ed.) Citation

S, S., E, M., P, V., & JE, M. (2025). The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 39(6), 815. https://doi.org/10.1007/s40259-025-00741-1

Chicago Style (17th ed.) Citation

S, Susin-Calle, Munteis E, Villoslada P, and Martinez-Rodriguez JE. "The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 39, no. 6 (2025): 815. https://doi.org/10.1007/s40259-025-00741-1.

MLA (9th ed.) Citation

S, Susin-Calle, et al. "The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 39, no. 6, 2025, p. 815, https://doi.org/10.1007/s40259-025-00741-1.